NCT07495514已完成1 期
An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of AD-117 in Healthy Adult Volunteers
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Maximum concentration of drug in plasma (Cmax)
研究概览
简要总结
A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers
详细描述
An open-label, randomized, single-dose, 2-sequence, 2-period, crossover study to evaluate the food effect on the safety and the pharmacokinetics of AD-117 in healthy adult volunteers
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
- •Healthy volunteers aged ≥19 and <65 years at the time of screening visit
排除标准
- •Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
- •Other exclusions applied
结局指标
主要结局
Maximum concentration of drug in plasma (Cmax)
时间窗: 0-72 hours
Cmax of AD-117
Area under the plasma concentration-time curve during dosing interval (AUCt)
时间窗: 0-72 hours
AUCt of AD-117
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
1 期
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsHealthy VolunteersNCT07570186Onconic Therapeutics Inc.36
尚未招募
1 期
Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male SubjectsSolid TumorIdiopathic Pulmonary FibrosisObesityNCT07682337SCBIO Inc.74
尚未招募
1 期
Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release TabletsT2DM (Type 2 Diabetes Mellitus)NCT07511010Chipscreen Biosciences, Ltd.28
招募中
不适用
A Single dose oral food effect bioavailability study of Usnoflast in healthy adult human subjects under fasting and fed conditions.CTRI/2025/11/098004Zydus Lifesciences Limited28
已完成
1 期
A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)AcromegalyNCT07663318Triastek (Shanghai) Limited18